IDXX
Price
$547.01
Change
+$4.30 (+0.79%)
Updated
Jul 3 closing price
Capitalization
44.84B
30 days until earnings call
SUVPF
Price
$259.02
Change
+$2.21 (+0.86%)
Updated
May 16 closing price
Capitalization
25.41B
Interact to see
Advertisement

IDXX vs SUVPF

Header iconIDXX vs SUVPF Comparison
Open Charts IDXX vs SUVPFBanner chart's image
IDEXX Laboratories
Price$547.01
Change+$4.30 (+0.79%)
Volume$339.03K
Capitalization44.84B
Sartorius AG
Price$259.02
Change+$2.21 (+0.86%)
Volume$1
Capitalization25.41B
IDXX vs SUVPF Comparison Chart in %
Loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUVPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDXX vs. SUVPF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Buy and SUVPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (IDXX: $547.01 vs. SUVPF: $259.02)
Brand notoriety: IDXX and SUVPF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 57% vs. SUVPF: 67%
Market capitalization -- IDXX: $44.84B vs. SUVPF: $25.41B
IDXX [@Medical Specialties] is valued at $44.84B. SUVPF’s [@Medical Specialties] market capitalization is $25.41B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 2 FA rating(s) are green whileSUVPF’s FA Score has 1 green FA rating(s).

  • IDXX’s FA Score: 2 green, 3 red.
  • SUVPF’s FA Score: 1 green, 4 red.
According to our system of comparison, IDXX is a better buy in the long-term than SUVPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 5 TA indicator(s) are bullish while SUVPF’s TA Score has 3 bullish TA indicator(s).

  • IDXX’s TA Score: 5 bullish, 4 bearish.
  • SUVPF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, SUVPF is a better buy in the short-term than IDXX.

Price Growth

IDXX (@Medical Specialties) experienced а +3.64% price change this week, while SUVPF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

IDXX is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDXX($44.8B) has a higher market cap than SUVPF($25.4B). IDXX (52.87) and SUVPF (51.55) have similar P/E ratio . IDXX YTD gains are higher at: 32.307 vs. SUVPF (17.824). SUVPF (1.24B) and IDXX (1.22B) have comparable annual earnings (EBITDA) . IDXX has more cash in the bank: 454M vs. SUVPF (210M). IDXX has less debt than SUVPF: IDXX (1.07B) vs SUVPF (2.77B). SUVPF has higher revenues than IDXX: SUVPF (3.85B) vs IDXX (3.66B).
IDXXSUVPFIDXX / SUVPF
Capitalization44.8B25.4B176%
EBITDA1.22B1.24B98%
Gain YTD32.30717.824181%
P/E Ratio52.8751.55103%
Revenue3.66B3.85B95%
Total Cash454M210M216%
Total Debt1.07B2.77B38%
FUNDAMENTALS RATINGS
IDXX vs SUVPF: Fundamental Ratings
IDXX
SUVPF
OUTLOOK RATING
1..100
2950
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
1785
PRICE GROWTH RATING
1..100
1547
P/E GROWTH RATING
1..100
4516
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SUVPF's Valuation (87) in the null industry is in the same range as IDXX (88) in the Medical Specialties industry. This means that SUVPF’s stock grew similarly to IDXX’s over the last 12 months.

IDXX's Profit vs Risk Rating (56) in the Medical Specialties industry is somewhat better than the same rating for SUVPF (100) in the null industry. This means that IDXX’s stock grew somewhat faster than SUVPF’s over the last 12 months.

IDXX's SMR Rating (17) in the Medical Specialties industry is significantly better than the same rating for SUVPF (85) in the null industry. This means that IDXX’s stock grew significantly faster than SUVPF’s over the last 12 months.

IDXX's Price Growth Rating (15) in the Medical Specialties industry is in the same range as SUVPF (47) in the null industry. This means that IDXX’s stock grew similarly to SUVPF’s over the last 12 months.

SUVPF's P/E Growth Rating (16) in the null industry is in the same range as IDXX (45) in the Medical Specialties industry. This means that SUVPF’s stock grew similarly to IDXX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXSUVPF
RSI
ODDS (%)
Bearish Trend 2 days ago
60%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
49%
Advances
ODDS (%)
Bullish Trend 2 days ago
68%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
70%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
69%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUVPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLDB5.030.16
+3.29%
Solid Biosciences
ADPT11.800.32
+2.79%
Adaptive Biotechnologies Corp
PNW90.420.25
+0.28%
Pinnacle West Capital Corp
HBANP17.63N/A
N/A
Huntington Bancshares
PPIH23.98-0.09
-0.35%
Perma-Pipe International Holdings

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with A. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
+0.79%
A - IDXX
51%
Loosely correlated
+0.60%
RVTY - IDXX
51%
Loosely correlated
+0.41%
MTD - IDXX
50%
Loosely correlated
+0.28%
IQV - IDXX
49%
Loosely correlated
-0.25%
SYK - IDXX
49%
Loosely correlated
+0.89%
More

SUVPF and

Correlation & Price change

A.I.dvisor tells us that SUVPF and TLSI have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SUVPF and TLSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUVPF
1D Price
Change %
SUVPF100%
N/A
TLSI - SUVPF
27%
Poorly correlated
+3.47%
IDXX - SUVPF
23%
Poorly correlated
+0.79%
SOAGY - SUVPF
21%
Poorly correlated
-2.07%
SAUHF - SUVPF
20%
Poorly correlated
-1.29%
UEEC - SUVPF
18%
Poorly correlated
-6.81%
More